Going for a regular eye check-up is about more than assessing your ability to see. Your eyes can be a window to early ...

Also, at the outpatient department records of the National Radiotherapy Oncology and Nuclear Medicine Centre (NRONMC), KBTH, the total number of new head and neck cancer cases in 2024 was 292, 11.1% ...

As we age, our vision undergoes natural changes, including difficulty focusing on near objects (presbyopia) and reduced light ...

Thermolactyl isn’t particularly groundbreaking or innovative in an era when fabrics have been engineered to take heat retention and sweat wicking to new heights, but it’s still a great base layer ...

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Panelists discuss how key biologic and clinical distinctions—such as ischemia, leakage patterns, and modality-specific ...

Panelists discuss how differing disease mechanisms, inflammatory drivers, and clinical priorities across AMD, DME, and RVO ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

A new study in mice shows that briefly anesthetizing the retina of the weaker eye can restore its neural influence in the adult visual cortex.

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to ...